In addition, it is hypothesized that WISP-2 is significant in preventing the progression of pancreatic cancer, as it is involved in morphological alterations during the mesenchymal to epithelial transition of pancreatic adenocarcinoma and breast cancer cells (21,22). Here, CCN5 is linked to pancreatic neoplasm.